1. 1018PProgression of disease within 2 years (POD24) is a clinically significant endpoint to identify follicular lymphoma patients with high risk of death. (23rd October 2018) Authors: Sortais, C; Lok, A; Gastinne, T; Mahé, B; Dubruille, V; Blin, N; Howlett, S; Tabah, A; Arnaud, P; Moreau, A; Moreau, P; Leux, C; Le Gouill, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗